The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...

GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...

Long-term nemolizumab use reduces itch, disease severity, and steroid dependence in patients with prurigo nodularis in a ...

PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in Malaysia ...

Mirum Pharmaceuticals stock surged 25% and how LIVMARLI drives growth. Explore future prospects with Volixibat. Click here to ...

Cannabidiol (CBD) is “effective in reducing itching and improving the quality of life of patients with atopic dermatitis”, according to a new study. The study, conducted by researchers from the ...

Remibrutinib results in significant improvement in composite measure of itching and hives after second-generation H1-antihistamine treatment.

Tracy Morgan has been left unable to leave her home and spends each day feeling like her whole body is on fire ...

Tracy says living with her condition is unbearable and it took 13 years to get a diagnosis - but there is no cure ...

Cellulitis is a skin infection that can occur when bacteria enter an open bug bite. Early treatment is crucial. Learn how to ...

Spring is just around the corner, and arriving with the more pleasant weather are those most unpleasant pests: fleas and ...

Lebrikizumab is comparable or superior to many advanced systemic monotherapies for the short-term treatment of atopic dermatitis.